FLS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Flowserve is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has positive momentum and constructive sentiment from hedge funds and most analysts, but the recent guidance cut, activist criticism, and the lack of a clear proprietary buy signal make this more of a hold than an immediate buy. If forced to act today, I would not initiate a full long-term position here.
FLS is in a short-term bullish trend: MACD histogram is positive and expanding, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. Price at 75.24 is just above the R1 level of 74.019 and below R2 at 76.918, showing strength near resistance. RSI_6 at 72.776 signals the stock is somewhat stretched, even though it is described as neutral in the provided feed. Overall, the chart is constructive but not an ideal low-risk entry for a beginner who wants to buy immediately.
["Hedge funds are buying, with buying activity up 262.44% over the last quarter.", "Most analysts remain bullish, with several Buy/Outperform ratings and price targets in the low-to-mid 80s and low 90s.", "Starboard highlights long-term upside from the nuclear market, with about 20% of backlog tied to nuclear.", "Technical trend is positive, with bullish moving averages and expanding MACD.", "Options sentiment is bullish based on low put-call ratios."]
["The company cut its FY2026 sales forecast, which triggered a 13% stock drop since April 29.", "Starboard criticized execution and said Flowserve's 20% operating margin target trails the 23% peer median.", "Goldman Sachs is cautious and holds only a Neutral rating, citing risk to organic growth guidance.", "Near-term setup is described by multiple analysts as difficult, with fears of further estimate cuts.", "No AI Stock Picker or SwingMax signal is present today."]
Latest quarter financials were not fully provided, so detailed revenue and earnings growth cannot be assessed. The available commentary says Flowserve exceeded Q1 earnings expectations but cut its sales forecast for FY2026, implying that earnings quality was acceptable while revenue growth expectations weakened. The latest quarter season is Q1 2026, and the market reaction suggests investors focused more on the reduced sales outlook than the earnings beat.
Analyst sentiment is still mostly positive, but targets have been cut across the board after Q1 results. TD Cowen cut its target to $85 and kept Buy, Baird cut to $91 and kept Outperform, Stifel cut to $92 and kept Buy, Citi cut to $92 and kept Buy, Jefferies initiated at $90 with Buy, while Goldman Sachs reduced to $83 and kept Neutral. The overall Wall Street view is mixed-to-bullish: pros see margin expansion, nuclear opportunity, and a recovery in the second half or FY27+, while cons focus on weak near-term growth, execution issues, and the risk of further estimate cuts.
